← Back

Wire · opportunities

Ladera Medical Presents Full FASTEN Results Showing…

Published

22 November 2026

Topic

opportunities

◆ Sectors

Medtech

◆ Geography

Australia

◆ Source

Read at aapnews.aap.com.au →

◆ Verified

Fusion42 · 22 November 2026 · Fusion42 review

Ladera Medical presented full results from the FASTEN trial demonstrating that its Large Bore Closure System achieves rapid hemostasis and a strong safety profile in 55 patients undergoing transfemoral TAVR/TAVI procedures with 98.1% freedom from major access-site complications at 30 days.

This Wire brief sits within Fusion42's coverage of Medtech, and 2 sources have reported it.

◆ ◆ The Wire takeaway

You have a new, single-device option that closes large arterial punctures quickly without leaving implants inside the artery. This changes operational risks for cardiovascular interventionists and opens a door to tighter procedural workflows.

◆ Coverage

2 sources · 22 Nov 2026

◆ Related on Wire

◆ Topics

Medtechmedtechcardiovascularvascular-closureclinical-trialdevice-innovation